Insider Transactions in Q2 2023 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2023
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,010,000
+6.38%
|
$19,190,000
$19.26 P/Share
|
|
Jun 22
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,437
-3.16%
|
$236,303
$19.12 P/Share
|
|
Jun 16
2023
|
Juan C. Jaen President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,820
-1.51%
|
$91,580
$19.35 P/Share
|
|
Jun 16
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,563
-3.09%
|
$238,697
$19.35 P/Share
|
|
Jun 16
2023
|
Carolyn C. Tang General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,892
-2.93%
|
$54,948
$19.35 P/Share
|
|
Jun 16
2023
|
Terry J Rosen Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,762
-0.22%
|
$166,478
$19.35 P/Share
|
|
Jun 15
2023
|
Juan C. Jaen President |
SELL
Bona fide gift
|
Direct |
6,000
-1.85%
|
-
|
|
Jun 15
2023
|
Andrew J Perlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+24.53%
|
-
|
|
Jun 15
2023
|
Nicole Lambert Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+30.36%
|
-
|
|
Jun 15
2023
|
Patrick Machado Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+28.69%
|
-
|
|
Jun 15
2023
|
Antoni Ribas Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+23.65%
|
-
|
|
Jun 15
2023
|
David L. Lacey Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+12.13%
|
-
|
|
Jun 15
2023
|
Kathryn E Falberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+12.66%
|
-
|
|
Jun 15
2023
|
Kathryn E Falberg Director |
SELL
Bona fide gift
|
Direct |
50,504
-55.74%
|
-
|
|
Jun 15
2023
|
Yasunori Kaneko Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,800
+50.0%
|
-
|
|
Jun 07
2023
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,049
-6.38%
|
$80,980
$20.04 P/Share
|